Prospective Clinical Assessment Study in Children with Hypochondroplasia

Description

This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).

Conditions

Hypochondroplasia

Study Overview

Study Details

Study overview

This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).

Prospective Clinical Assessment Study in Children with Hypochondroplasia: ACCEL

Prospective Clinical Assessment Study in Children with Hypochondroplasia

Condition
Hypochondroplasia
Intervention / Treatment

-

Contacts and Locations

Oakland

UCSF Benioff Children's Hospital, Oakland, California, United States, 94609

Aurora

Childrens Hospital Colorado, Aurora, Colorado, United States, 80045

Washington DC

Children's National Hospital, Washington DC, District of Columbia, United States, 20010

Baltimore

Johns Hopkins School of Medicine, Baltimore, Maryland, United States, 21287

Columbia

University of Missouri, Columbia, Missouri, United States, 65201

Nashville

Vanderbilt University Medical Center, Nashville, Tennessee, United States, 37232

Madison

University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison, Wisconsin, United States, 53705

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    30 Months to 16 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    QED Therapeutics, Inc.,

    Study Record Dates

    2026-10